BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 35547360)

  • 1. Pharmacological Therapies for the Management of Inflammatory Bone Resorption in Periodontal Disease: A Review of Preclinical Studies.
    Pavanelli ALR; de Menezes BS; Pereira EBB; de Souza Morais FA; Cirelli JA; de Molon RS
    Biomed Res Int; 2022; 2022():5832009. PubMed ID: 35547360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periodontal Disease as a Risk Factor for Rheumatoid Arthritis: A Systematic Review.
    Kaur S; White S; Bartold M
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-12. PubMed ID: 27820156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytocystatin CsinCPI-2 Reduces Osteoclastogenesis and Alveolar Bone Loss.
    Da Ponte Leguizamón N; de Molon RS; Coletto-Nunes G; Nogueira AVB; Rocha SV; Neo-Justino DM; Soares-Costa A; Cerri PS; Lerner UH; Souza PPC; Cirelli JA
    J Dent Res; 2022 Feb; 101(2):216-225. PubMed ID: 34328027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates in periodontal treatment: a review.
    Badran Z; Kraehenmann MA; Guicheux J; Soueidan A
    Oral Health Prev Dent; 2009; 7(1):3-12. PubMed ID: 19408809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimentally induced periodontitis in beagle dogs causes rapid increases in osteoclastic resorption of alveolar bone.
    Shibutani T; Murahashi Y; Tsukada E; Iwayama Y; Heersche JN
    J Periodontol; 1997 Apr; 68(4):385-91. PubMed ID: 9150045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of ligature-induced experimental periodontitis.
    de Molon RS; Park CH; Jin Q; Sugai J; Cirelli JA
    Microsc Res Tech; 2018 Dec; 81(12):1412-1421. PubMed ID: 30351474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The silencing of cathepsin K used in gene therapy for periodontal disease reveals the role of cathepsin K in chronic infection and inflammation.
    Chen W; Gao B; Hao L; Zhu G; Jules J; MacDougall MJ; Wang J; Han X; Zhou X; Li YP
    J Periodontal Res; 2016 Oct; 51(5):647-60. PubMed ID: 26754272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response: the key to bone resorption in periodontal disease.
    Taubman MA; Valverde P; Han X; Kawai T
    J Periodontol; 2005 Nov; 76(11 Suppl):2033-41. PubMed ID: 16277573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR4 signaling contributes to alveolar bone resorption in Porphyromonas gingivalis-induced periodontitis in mice.
    Nagashima H; Shinoda M; Honda K; Kamio N; Hasuike A; Sugano N; Arai Y; Sato S; Iwata K
    J Oral Sci; 2017 Dec; 59(4):571-577. PubMed ID: 29093284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of topical administration of monosodium olpadronate on experimental periodontitis in rats.
    Goya JA; Paez HA; Mandalunis PM
    J Periodontol; 2006 Jan; 77(1):1-6. PubMed ID: 16579696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Odanacatib, A Cathepsin K-Specific Inhibitor, Inhibits Inflammation and Bone Loss Caused by Periodontal Diseases.
    Hao L; Chen J; Zhu Z; Reddy MS; Mountz JD; Chen W; Li YP
    J Periodontol; 2015 Aug; 86(8):972-83. PubMed ID: 25879791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of Bone Resorption in Periodontitis.
    Hienz SA; Paliwal S; Ivanovski S
    J Immunol Res; 2015; 2015():615486. PubMed ID: 26065002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periodontal disease and bone pathogenesis: the crosstalk between cytokines and porphyromonas gingivalis.
    Ballini A; Cantore S; Farronato D; Cirulli N; Inchingolo F; Papa F; Malcangi G; Inchingolo AD; Dipalma G; Sardaro N; Lippolis R; Santacroce L; Coscia MF; Pettini F; De Vito D; Scacco S
    J Biol Regul Homeost Agents; 2015; 29(2):273-81. PubMed ID: 26122214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte colony-stimulating factor (G-CSF) mediates bone resorption in periodontitis.
    Yu H; Zhang T; Lu H; Ma Q; Zhao D; Sun J; Wang Z
    BMC Oral Health; 2021 Jun; 21(1):299. PubMed ID: 34118920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone and Calcium Metabolisms Associated with Dental and Oral-Maxillofacial Diseases. Destructive bone resorption by osteoclasts and oral disease].
    Nakamura M; Koide M; Nakamura H; Udagawa N
    Clin Calcium; 2015 Sep; 25(9):1376-84. PubMed ID: 26320538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Basis beyond Interrelated Bone Resorption/Regeneration in Periodontal Diseases: A Concise Review.
    Sadek KM; El Moshy S; Radwan IA; Rady D; Abbass MMS; El-Rashidy AA; Dörfer CE; Fawzy El-Sayed KM
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The blockade of kappa opioid receptors exacerbates alveolar bone resorption in rats.
    D'Ângelo MQ; Queiroz-Junior CM; Maltos KLM; Ferreira AJ; Pacheco CMDF; Soares RV
    Arch Oral Biol; 2020 Dec; 120():104923. PubMed ID: 33091661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occlusal trauma accelerates attachment loss at the onset of experimental periodontitis in rats.
    Nakatsu S; Yoshinaga Y; Kuramoto A; Nagano F; Ichimura I; Oshino K; Yoshimura A; Yano Y; Hara Y
    J Periodontal Res; 2014 Jun; 49(3):314-22. PubMed ID: 23808820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boldine inhibits the alveolar bone resorption during ligature-induced periodontitis by modulating the Th17/Treg imbalance.
    Cafferata EA; Castro-Saavedra S; Fuentes-Barros G; Melgar-Rodríguez S; Rivera F; Carvajal P; Hernández M; Cortés BI; Cortez C; Cassels BK; Vernal R
    J Periodontol; 2021 Jan; 92(1):123-136. PubMed ID: 32490537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NLRC4 inflammasome has a protective role on inflammatory bone resorption in a murine model of periodontal disease.
    Rocha FRG; Delitto AE; de Souza JAC; Maldonado LAG; Wallet SM; Rossa C
    Immunobiology; 2020 Jan; 225(1):151855. PubMed ID: 31848028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.